References:
1. Chatelon J et al. Adv Ther. 2019;36(12):3308–3320.
2. Peman J et al. Rev Iberoam Micol. 2020;37(2):41–46.
3. Bongomin F et al. J Fungi (Basel). 2017;3(4):57.
4. De Pascale G et al. Curr Opin Crit Care. 2015;21:421–429.
5. Gangneux JP et al. J Mycol Méd. 2020;30:100971.
6. AmBisome® Summary of Product Characteristics (UK). Available
at: https://www.medicines.org.uk/emc/product/1022/smpc#gref.
[Last accessed: March 2023].
at: https://www.medicines.org.uk/emc/product/1022/smpc#gref.
[Last accessed: March 2023].
7. Lass-Flörl C et al. Antimicrob Agents Chemother. 2008;52(10):3637–3641.
8. Cornely OA et al. Clin Infect Dis. 2007;44(10):1289–1297.
9. Álvarez-Lerma F et al. J Chemother. 2009;21(3):330–337.
10. Almyroudis NG et al. Antimicrob Agents Chemother. 2007;51(7):2587–2590.
11. Chandrasekar P. J Antimicrob Chemother. 2011;66:457–465.
13. Meletiadis J et al. J Antimicrob Agents Chemother. 2007;51(9):3329–3337.
14. Mercier T et al. Crit Care. 2020;24:642.
15. Pappas PG et al. Nat Rev Dis Primers. 2018;4:18026.
16. Kuse E-R et al. Lancet. 2007;369(9572):1519–1527.
17. Walsh TJ et al. N Engl J Med. 2002;346(4):225–234.
18. Walsh TJ et al. N Engl J Med. 1999;340(10):764–771.
19. Walsh TJ et al. N Engl J Med. 2004;351(14):1391–1402.
20. Hamill RJ et al. Clin Infect Dis. 2010;51(2):225–232.
21. Wheat LG et al. Antimicrob Agents Chemother. 2001;45(8):2354–2357.
22. Wheat J et al. Medicine (Baltimore). 2018;97(13):e0245.
23. Johnson PC et al. Ann Intern Med. 2002;137(2):105–109.
